After adults, Chinese drugmaker Sinovac to begin with CoronaVac vaccine trial on teenagers

Chinese pharmaceutical company Sivac Biotech plans to broen testing of its Coronavirus vaccine trials with teenrs later this month. China's Sivac vaccine is currently in its Phase III trials with ults. According to a registration published earlier this week, a total of 552 healthy participants d between 3 and 17 years will take two doses of Sivac's CoroaVac vaccine on September 28 in rr Chinese Provine of Hebei. 

Sivac's CoronaVac to begin its trials on teenrs 

Chinese drugmaker is all set to begin its CoronaVac vaccine trials on children and olescents after getting approval for same. reports of Sivac's vaccine trials so far reveal that vaccine is safe and it was successful in generating antibodies in older people. China's Sivac injected its 3,000 employees and ir family members with vaccine to meet company's target of obtaining a production license by end of 2020. company informed that apart from this, doses of Coronavirus vaccine was injected to protect employees from rebound of epidemic in winters. 

RE | China Condemns US Envoy's Visit To Taiwan, Says It Will Encour 'separatist Forces'

China recorded its first COVID-19 case last December 2019, in a wholesale market in Wuhan. Despite fact that spre of Coronavirus has been controlled in country, strict preventive measures along with international travel bans by government still remain in place. Sivac is one of three Chinese companies which are currently in its Phase III trials for Coronavirus vaccine under government-approved fast-track program. Besides China, vaccine trials are also taking place in Indonesia and Brazil. 

RE | China: Thousands Infected With Bacterial Disease After Leak At Biopharmaceutical Factory

company said that it is capable of producing 300 million doses of its CoronaVac vaccine and hopes to go into mass production by end of year. Last month, it signed an agreement with Indonesia's PT Bio Farma to supply 40 million doses of Coronavirus vaccine before March 2021. Sivac's president Yin Weidong on Sunday said that Sivac will only consider densely populated countries with huge outbreaks having very few research development capabilities as its export markets. 

RE | Chinese Spying: Plea In SC Seeks Probe Into Zhenhua Data, Ban On China-backed 'loan Apps'

COVID-19 vaccines across globe 

China in July approved emergency use of Coronavirus vaccines for military and front line health care workers. State-owned pharmaceutical company Siphram Group offered free injections of its COVID-19 vaccine while ramping up production of 300 million doses annually. Siphram hopes to commercialize its COVID-19 vaccine by end of 2020 and will price m under 1,000 ($147) yuan for two doses. 

Last month Russia became first country to approve a Coronavirus vaccine with a personal endorsement by President Vlimir Putin who gave vaccine dose to his daughter while vaccine h t undergone Phase III clinical trials. Witnessing race to get get Coronvirus approved across globe World Health Organization said that despite fact that vaccine is important in battle against pandemic, it would t help to extinguish COVID-19 completely. Finding such a vaccine which can completely extinguish Corovirus will t be easy. 

RE | Chinese Data Firm Zhenhua Data 'spied' On 10,000 Eminent Indians; Here Are Details